Advertisement
| biotechnology law report: Biotechnology, Patenting Issues Robert D. Warmbrodt, 1992 |
| biotechnology law report: Biotechnology, Legislation and Regulation Robert D. Warmbrodt, 1991 |
| biotechnology law report: Biotechnology Education Report , 1983 |
| biotechnology law report: Intellectual Property and Biotechnology Matthew Rimmer, 2008-01-01 Dr Rimmer s book is a marvellous introduction to a crucial topic of our time. He writes engagingly, provocatively and always with good humour. A highly technical and complex area of law has been reduced to clear descriptions and searching analysis. Truly, this is an important book on an essential topic that will help define the ethics of a future that includes nothing less than the future of our species. From the foreword by the Hon Justice Michael Kirby AC CMG, the High Court of Australia . . . the author has done an excellent job by explaining the subject in an open and accessible manner. This book is a timely and very thought-provoking analysis of patent law and biotechnology. . . The book is a unique theoretical contribution to the controversial public debate over commercialization of biological inventions. . . there is an extensive bibliography. . . a valuable resource for further reading. The book will be of prime interest to lawyers and patent attorneys, scientists and researchers, business managers and technology transfer specialists. Journal of Intellectual Property Rights Rimmer s book is highly recommended for anyone interested in the issues and debate related to biological inventions, regardless of which side the reader is on. Stefan M. Miller, Journal of Commercial Biotechnology . . . this book gives an excellent account of the most celebrated biotechnology cases from three continents, and for this alone is to be thoroughly recommended. David Rogers, European Intellectual Property Review Rimmer has put a great deal of thought and effort into this series of chapters. For those looking at how to reform, direct and develop laws in relation to biotechnology, this book is brimming with ideas, suggestions and recommendations of what to do next. Rebecca Halford-Harrison, Chartered Institute of Patent Attorneys . . . an excellent introduction to a wide range of legal thinking in an increasingly controversial and relevant area to humankind. Sharon Givoni, Australian Intellectual Property Law Bulletin Rimmer s new book is a timely and very thought-provoking analysis of patent law and biotechnology and asks a very serious question: can a 19th century patent system adequately deal with a 21st century industry? Kate McDonald, Australian Life Scientist This book documents and evaluates the dramatic expansion of intellectual property law to accommodate various forms of biotechnology from micro-organisms, plants, and animals to human genes and stem cells. It makes a unique theoretical contribution to the controversial public debate over the commercialization of biological inventions. The author also considers the contradictions between the Supreme Court of Canada rulings in respect of the Harvard oncomouse, and genetically modified canola. He explores law, policy, and practice in both Australia and New Zealand in respect to gene patents and non-coding DNA. This study charts the rebellion against the European Union Biotechnology Directive particularly in respect of Myriad Genetics BRCA1 and BRCA2 patents, and stem cell patent applications. The book also considers whether patent law will accommodate frontier technologies such as bioinformatics, haplotype mapping, proteomics, pharmacogenomics, and nanotechnology. Intellectual Property and Biotechnology will be of prime interest to lawyers and patent attorneys, scientists and researchers, business managers and technology transfer specialists. |
| biotechnology law report: Commercial biotechnology : an international analysis. , |
| biotechnology law report: Commercial Biotechnology , 1984 |
| biotechnology law report: Biotechnology and Intellectual Property Rights Kshitij Kumar Singh, 2014-10-27 This book offers a valuable contribution to contemporary legal literature, providing deep insights into the interface between law and genetics, highlighting emerging issues and providing meaningful solutions to current problems. It will be of interest to a broad readership, including academics, lawyers, policy makers and scholars engaged in interdisciplinary research. In the context of examining and analyzing the legal and social implications arising from the recent conjunction of biotechnology and intellectual property rights, the book particularly focuses on human genes and gene variations. Emphasis is placed on “patent law,” as a considerable percentage of genetic inventions are covered by patents. The book presents a comparative and critical examination of patent laws and practices related to biotechnology patents in the United States, Canada, European Union and India, in order to gather the common issues and the differences between them. The international patent approach regarding biotechnology is also analyzed in light of the constant conflict between differentiation and harmonization of patent laws. The book highlights the potential gaps and uncertainties as to the scope of numerous terms such as invention, microorganisms, microbiological processes, and essential biological processes under TRIPS. Also analyzed are the social and policy implications of patents relating to genetic research tools and genetic testing. The intricacies involved in providing effective intellectual property protection to bioinformatics and genomic databases are also examined. Bearing in mind the collaborative nature of bioinformatics and genomic databases, the book evaluates the pros and cons of open biotechnology and assesses the implications of extending intellectual property rights to human genetic resources, before explaining the ownership puzzle concerning human genetic material used in genetic research. |
| biotechnology law report: Biotechnology, Patenting Issues Suzanne Nanis, 1990 |
| biotechnology law report: EU Biotechnology Law & Practice Brian Sheridan, 2001 EU biotechnology law and practice: regulating genetically modified and novel food products. |
| biotechnology law report: Biotechnology and the Law Hugh B. Wellons, 2007 The book is written to help lawyers faced with the challenge of identifying the legal issues and processes that must be faced by their clients in building, marketing, and protecting a biotech business. The contributors are experts in this specialized area and provide thorough, yet accessible, overviews of biotech subspecialties with an eye to practical application. A biotech legal practice involves specialized subject matter and regulatory schemes that, generally, are not part of the business lawyer's repertoire and which can present many hazards for the uninitiated. Because of the expansion in biotech practice beyond the traditional organizations and their representatives, this guide was written to help lawyers find their way through the biotech maze. |
| biotechnology law report: The Nexus of Law and Biology Barbara Ann Hocking, 2016-02-17 Although law and science have interacted for centuries, today their interactions pose enormous challenges. These challenges are reflected in issues ranging from reproductive technology and resource conservation, to genetic technology and biological warfare. The emerging dialogue is complex and requires an ongoing re-thinking of general principles, such as expert biological evidence, which features in a wide range of legal contexts, and including medical law, torts, crime and intellectual property. Studying the many ways in which law and biology come together in many areas of contemporary life, The Nexus of Law and Biology: New Ethical Challenges explores the juridical uses of biological sciences to illuminate key issues and contemporary intersections, arguing that each of several disciplines must communicate with one another, recognizing a common ground in ethics. Featuring an impressive list of contributors, this book is an invaluable reference for legal scholars, students, practising lawyers and scientists engaged with the legal system. |
| biotechnology law report: Journal Holdings Report United States. Environmental Protection Agency. Information Management and Services Division, 1989 |
| biotechnology law report: The Intellectual Property–Regulatory Complex Emily Marden, R. Nelson Godfrey, Rachael Manion, 2016-03-06 Advances in agricultural genomics could help address pressing global issues, such as world hunger, by improving crop yield. However, overlap and conflict in intellectual property and biosafety regimes – known collectively as the “Intellectual Property–Regulatory Complex” – create significant barriers to innovation. In this collection, leading legal, policy, and economics experts analyze the impact of the Complex on agricultural genomics. They reveal how it impacts scientific advancement in ways that are underappreciated when intellectual property and biosafety regimes are examined in isolation. After identifying how the interplay between multiple regimes impedes research, development, and product distribution, they propose solutions that would further the aims of the current intellectual property and biosafety regimes while enabling growth and innovation in agricultural genomics. |
| biotechnology law report: The Black Book Meera Kaura Patel, 2011 |
| biotechnology law report: The Prospects of International Trade Regulation Thomas Cottier, Panagiotis Delimatsis, 2011-04-14 For a long time, the GATT led a life of its own as a self-contained regime. The evolution from tariff to non-tariff barriers brought about increasing overlaps with other regulatory areas. WTO rules increasingly interface with other areas of law and policy, including environmental protection, agricultural policies, labour standards, investment, human rights and regional integration. Against this backdrop, this book examines fragmentation in international trade regulation across a wide array of regulatory fields. To this end, it uses a conceptually coherent theoretical framework which is based on the effort to bring about greater coherence among different policy goals and fields, and thus to embed the multilateral trading system within the broader framework of international economics, law and relations. It will appeal to those interested in a forward-looking discussion of the most pressing issues of the international trade agenda. |
| biotechnology law report: Regulating Genetically Modified Crops in View of Environmental Risks Ancui Liu, 2022-05-25 This book analyzes international and Chinese regulatory approaches addressing environmental risks that may be caused by GM crops and examines how China implements its international obligations in its policies and laws. Using the legal doctrinal method, the book discusses the precautionary principle and the public involvement principle, as well as several legal measures at the international law level and in Chinese law. It observes that legal principles and measures as provided for in China’s GMO legal framework have generally implemented the international obligations regarding the prevention of environmental risks that may be caused by the cultivation of GM crops and related activities. However, the book argues that Chinese law lacks an explicit codification of the precautionary principle, and the same is true with regard to public participation; the regulatory framework lacks specific obligations. It concludes that future research should focus on the application and enforcement of the relevant Chinese legislation, and that it is also important to investigate how the environmental risks that may be caused by new techniques, such as genome-editing techniques, could be prevented, given the experience gained by regulating the cultivation of GM crops and related activities. |
| biotechnology law report: Supplementary Protection Certificates for Medicinal Products Georgia A. Roussou, 2023-01-20 This book explores whether the judicial developments related to the Supplementary Protection Certificate (SPC) regulation correspond to the objectives of the European legislator. Examining the role of SPCs for medicinal products in the European patent system, it highlights both the jurisprudence of the Court of Justice of the European Union and the respective judgements of the member states’ national courts. |
| biotechnology law report: Biotechnological Inventions and Patentability of Life Andrea Stazi, 2015-05-29 In todayês technological world, biotechnology is one of the most innovative and highly invested-in industries for research, in the field of science. This book analyses the forms and limitations of patent protection recognition for biotechnological inve |
| biotechnology law report: Biotechnology Entrepreneurship Craig Shimasaki, 2020-05-16 This second edition of Biotechnology Entrepreneurship: Leading, Managing, and Commercializing Innovative Technologies is an authoritative, easy-to-read guide covering biotechnology entrepreneurship and the process of commercializing innovative biotechnology products. This best practice resource is for professional training programs, individuals starting a biotech venture, and for managers and experienced practitioners leading biotech enterprises. It is a valuable resource for those working at any level in the biotech industry, and for professionals who support and provide essential resources and services to the biotech industry. This practical, how-to book is written by seasoned veterans experienced in each of the operational functions essential for starting, managing, and leading a successful biotech company.Biotechnology Entrepreneurship explains the biotech business components and underlying strategies, interspersed with practical lessons from successful biotech entrepreneurs, educators, and experienced practitioners. These veteran contributors share their insights on how to be successful in this challenging but exciting industry. Subjects range from technology licensing and translating an idea into a viable business, forming your legal company entity, securing angel and venture capital, navigating product development, FDA regulatory approval, and biomanufacturing.This book is a user-friendly guide to decision-making and overall strategy written as a hands-on management tool for leaders and managers of these dynamic biotechnology ventures. If you are contemplating starting a biotech company, are a manager at any level, a seasoned veteran, or service provider in the biotech industry, this book is a must read.This second edition includes several new chapters on topics such as: - What you need to know about valuation and term sheets - Investor presentations and what you need in a biotech investor pitch deck - Mentorship and why you need mentors - Artificial intelligence applications in biotech and pharma - Common biotech entrepreneur mistakes and how to avoid them |
| biotechnology law report: Exploiting Biotechnology Alan Moses, 1995-06-30 Supplies basic knowledge of biotechnology; how products are chosen, manufactured and marketed as well as how new avenues for development are identified and managed. The authors discuss in simple, non-technical language the most relevant aspects of biology and chemistry, and go on to survey significant developments in biotechnology in recent years together with those likely to bear fruit in the years to come. Combined with technology, chapters on management, manufacturing, patents, regulation and public attitudes complete the picture. |
| biotechnology law report: Patenting Genes Marta Díaz Pozo, 2017-03-31 This book constitutes a fascinating and in-depth analysis of the significance of the requirement of industrial application within gene patenting and how this influences innovation in Europe and the US. The author addresses an area normally overlooked in biotechnology patenting due to the predominance of the ethical debate, and in doing so produces a unique approach to dealing with concerns in this field. |
| biotechnology law report: Current Catalog National Library of Medicine (U.S.), 1985 First multi-year cumulation covers six years: 1965-70. |
| biotechnology law report: National Library of Medicine Current Catalog National Library of Medicine (U.S.), 1985 |
| biotechnology law report: USDA Licensing of a Genetically Altered Veterinary Vaccine United States. Congress. House. Committee on Science and Technology. Subcommittee on Investigations and Oversight, 1986 |
| biotechnology law report: Intellectual Property and Emerging Technologies Matthew Rimmer, Alison McLennan, 2012-01-01 This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery. Extensive contributions examine recent controversial court decisions in patent law such as Bilski v. Kappos, and the litigation over Myriad's patents in respect of BRCA1 and BRCA2 while other papers explore sui generis fields, such as access to genetic resources, plant breeders' rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies. Intellectual Property and Emerging Technologies will appeal to policy-makers, legal practitioners, business managers, inventors, scientists and researchers. |
| biotechnology law report: Technology and Legal Systems Noel Cox, 2016-12-14 The advent of the knowledge economy and society has made it increasingly necessary for law reformers and policy makers to take account of the effects of technology upon the law and upon legal and political processes. This book explores aspects of technology's relationship with law and government, and in particular the effects changing technology has had on constitutional structures and upon business. Part I examines the legal normative influence of constitutional structures and political theories. It focuses on the interrelationship between laws and legal procedure with technology and the effect technology can have on the legal environment. Part II discusses the relationship between government and technology both at the national and international level. The author argues that technology must be contextualized within a constitution and draws on historical and contemporary examples to illustrate how technology has both shaped civilizations and been the product of its political and constitutional environment. |
| biotechnology law report: The Structure of Intellectual Property Law Annette Kur, Vytautas Mizaras, 2011-01-01 In 2009, the Association for the Advancement of Teaching and Research in Intellectual Property (ATRIP) dedicated its yearly congress to the theme Horizontal Issues in IP Law; Uncovering the Matrix. That theme and the main concern of the so-called Intellectual Property of Transition Project have been brought together by the editors of the current book under the intriguing title The Structure of Intellectual Property Law Questioned, is whether the apparent compartmentalisation and fragmentation of actual intellectual property law can be based upon a coherent system that supports the entire field. In other words: it is questioned whether one organising principle which underlies the different parts of this domain of law can be found. Not surprisingly, the answers given by the various experts that contribute to this book tend to differ, mainly depending on their field of interest: copyright law, patent law, trademark law, the main tendency being in favour of tailoring instead of unifying both from the perspective of efficiency and that of economics. However, even more interesting than the answers to the question posed, are the stimulating and thought-provoking analyses which the book offers. This is really a book one should read if one is interested in the conjunction of the basic principles of intellectual property law and how they work out in practice. Willem Grosheide, Utrecht University, The Netherlands Today, intellectual property is a broad genus embracing various more specific species - invention patents, copyright, trade marks and so forth. Anyone concerned with how this ever-expanding grouping is developing should read the fourteen essays in this book. Written by leading scholars, they tackle not only the relationships between the species, but also those between sub-species. Originally presented as papers to the Association for Teaching and Research in IP, the writing is both subtle and full of verve. Strongly recommended. William Cornish, Cambridge University, UK This well-researched and highly topical book analyses whether the ever-increasing degree of sophistication in intellectual property law necessarily leads to fragmentation and inconsistency, or whether the common principles informing the system are sustainable enough to offer a solid and resilient framework for legal development. |
| biotechnology law report: Plant Transformation Technologies Charles Neal Stewart, Alisher Touraev, Vitaly Citovsky, Tzvi Tzfira, 2011-01-31 Plant Transformation Technologies is a comprehensive, authoritative book focusing on cutting-edge plant biotechnologies, offering in-depth, forward-looking information on methods for controlled and accurate genetic engineering. In response to ever-increasing pressure for precise and efficient integration of transgenes in plants, many new technologies have been developed. With complete coverage of these technologies, Plant Transformation Technologies provides valuable insight on current and future plant transformation technologies. With twenty-five chapters written by international experts on transformation technologies, the book includes new information on Agrobacterium, targeting transgenes into plant genomes, and new vectors and market systems. Including both review chapters and protocols for transformation, Plant Transformation Technologies is vitally important to graduate students, postdoctoral students, and university and industry researchers. |
| biotechnology law report: The Gridlock Economy Michael Heller, 2010-02-23 25 new runways would eliminate most air travel delays in America. Why can't we build them? 50 patent owners are blocking a major drug maker from creating a cancer cure. Why won't they get out of the way? 90% of our broadcast spectrum sits idle while American cell phone service lags far behind Japan's and Korea's. Why are we wasting our airwaves? 98% of African American -- owned farms have been sold off over the last century. Why can't we stop the loss? All these problems are really the same problem -- one whose solution would jump-start innovation, release trillions in productivity, and help revive our slumping economy. Every so often an idea comes along that transforms our understanding of how the world works. Michael Heller has discovered a market dynamic that no one knew existed. Usually, private ownership creates wealth, but too much ownership has the opposite effect -- it creates gridlock. When too many people own pieces of one thing, whether a physical or intellectual resource, cooperation breaks down, wealth disappears, and everybody loses. Heller's paradox is at the center of The Gridlock Economy. Today's leading edge of innovation -- in high tech, biomedicine, music, film, real estate -- requires the assembly of separately owned resources. But gridlock is blocking economic growth all along the wealth creation frontier. A thousand scholars have applied and verified Heller's paradox. Now he takes readers on a lively tour of gridlock battlegrounds. Heller zips from medieval robber barons to modern-day broadcast spectrum squatters; from Mississippi courts selling African-American family farms to troubling New York City land confiscations; and from Chesapeake Bay oyster pirates to today's gene patent and music mash-up outlaws. Each tale offers insights into how to spot gridlock in operation and how we can overcome it. The Gridlock Economy is a startling, accessible biography of an idea. Nothing is inevitable about gridlock. It results from choices we make about how to control the resources we value most. We can unlock the grid; this book shows us where to start. |
| biotechnology law report: Newsletters Pertaining to Agricultural Biotechnology Robert D. Warmbrodt, 1991 |
| biotechnology law report: Collection Development in Sci-tech Libraries Ellis Mount, 1984 |
| biotechnology law report: GMOs and Political Stance Muhammad Amjad Nawaz, Gyuhwa Chung, Kirill Sergeyevich Golokhvast, Aristidis M. Tsatsakis, 2022-12-06 GMOS and Political Stance: Global GMO Regulation, Certification, Labeling, and Consumer Preferences provides a foundational-to-current challenges resource for those involved in developing and applying regulations to these important resources. Beginning with basics of GMOs, the book first familiarizes the reader with the history, economic status, associated risks, global politics, and socio-economics of GMOs. From exploring the necessity of GMO regulations with the existing GMO technology as well as new gene editing technologies to discussion by GMO regulations experts from different continents and countries, readers will find the information necessary to understand the laws, rules, regulations and policies at domestic and international scale. A last chapter delivers an update and future look on gene-edited food and feed and discusses the possibilities on the future risk assessment, legislation and regulation of gene-edited products. GMOS and Political Stance provides a unique and applicable synchronization of all regulatory information on GMOs to facilitate effective and efficient regulatory development and adherence. - Guides law and policy makers particularly from developing countries toward sound policies in line with international regulations - Presents a global overview of genetic modification of organisms and their emerging role in food supply - Provides insights into future risk assessment strategies and potential for new legislative process development |
| biotechnology law report: New Developments in Biotechnology , 1987 |
| biotechnology law report: Biotechnology and the Law , |
| biotechnology law report: Handbook of Agricultural Economics Robert E. Evenson, Prabhu Pingali, 2007-06-28 Volume 3 of this series of the Handbooks in Economics follows on from the previous two volumes by focusing on the fundamental concepts of agricultural economics. The first part of the volume examines the developments in human resources and technology mastery. The second part follows on by considering the processes and impact of invention and innovation in this field. The effects of market forces are examined in the third part, and the volume concludes by analysing the economics of our changing natural resources, including the past effects of climate change.Overall this volume forms a comprehensive and accessible survey of the field of agricultural economics and is recommended reading for anyone with an interest, either academic or professional, in this area.*Part of the renown Handbooks in Economics series*Contributors are leaders of their areas*International in scope and comprehensive in coverage |
| biotechnology law report: Research Handbook on Intellectual Property and the Life Sciences Duncan Matthews, Herbert Zech, 2017-06-30 Intellectual property (IP) is a key component of the life sciences, one of the most dynamic and innovative fields of technology today. At the same time, the relationship between IP and the life sciences raises new public policy dilemmas. The Research Handbook on Intellectual Property and the Life Sciences comprises contributions by leading experts from academia and industry to provide in-depth analyses of key topics including pharmaceuticals, diagnostics and genes, plant innovations, stem cells, the role of competition law and access to medicines. The Research Handbook focuses on the relationship between IP and the life sciences in Europe and the United States, complemented by country-specific case studies on Australia, Brazil, China, India, Japan, Kenya, South Africa and Thailand to provide a truly international perspective. |
| biotechnology law report: The Improving State of the World Indur M. Goklany, 2007 Relying on a wealth of data, Goklany shows how innovation, increases in affluence, and key institutions have combined to address environmental degradation that sometimes results from growth. The evidence on the use of cropland, trends in air pollution, and diverse experiences in water usage counters the gloomy outlook of some environmentalists. Goklany explains why the state of the world is improving and offers a realistic assessment of the sustainability of the human enterprise, setting priorities for dealing with such challenges as climate change. |
| biotechnology law report: Intangible Intangibles Brad Sherman, 2024-04-30 This book takes as its starting point recent debates over the dematerialisation of subject matter which have arisen because of changes in information technology, molecular biology, and related fields that produced a subject matter with no obvious material form or trace. Arguing against the idea that dematerialisation is a uniquely twenty-first century problem, this book looks at three situations where US patent law has already dealt with a dematerialised subject matter: nineteenth century chemical inventions, computer-related inventions in the 1970s, and biological subject matter across the twentieth century. In looking at what we can learn from these historical accounts about how the law responded to a dematerialised subject matter and the role that science and technology played in that process, this book provides a history of patentable subject matter in the United States. This title is available as Open Access on Cambridge Core. |
| biotechnology law report: Damage Caused by Genetically Modified Organisms Bernhard A. Koch, Bjarte Askeland, 2010 The debate about the use of genetically modified organisms in European agriculture is fuelled by the fear of the general public about potential risks of GM farming, whether substantiated or not. Transgenic food is suspected to cause bodily harm, have a negative impact upon the health of animals, weaken the productivity of conventional farmland, reduce biodiversity or otherwise deteriorate the environment, to name but a few dangers popping up in the public debate. Apart from setting standards for GM farming and requiring safety checks for transgenic products, all jurisdictions also provide for the case that such risks should materialize. These are not necessarily novel approaches - classic tort law already offers remedies for such losses. Sometimes these traditional solutions are enhanced or replaced by alternative redress schemes. This volume compares twenty European and four non-European jurisdictions in this respect and provides special analyses from an economic and insurance perspective as well as surveys of cross-border dispute resolution and international law. |
| biotechnology law report: Patents and the Constitution United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts, Civil Liberties, and the Administration of Justice, 1988 |
Biotechnology: what it is and how it's about to change our lives
Dec 20, 2016 · Biotechnology is a broad range of technologies that employ living organisms or parts of them to make diverse products. For example, drugs and therapeutics, nutritional …
Biotechnology: From transforming healthcare to transforming our …
Sep 14, 2023 · Embracing biotechnology as the world’s go-to commercialization technology serves as a pro-environment alternative that permits industries to move beyond fossil inputs …
Four problems that biotechnology can help solve - The World …
Jun 27, 2016 · Biotechnology offers some of the most promising and targeted ways to find solutions to these threats. For example, the British company Oxitec, a subsidiary of Intrexon …
Explaining biotechnology, its achievements and potential
Jan 16, 2025 · When the biotechnology community tells stories in unique ways that provide a sense of optimism, we can win people over and encourage the adoption of new innovations …
How could biotechnology improve your life? - The World …
Feb 25, 2013 · Biotechnology has the potential to provide the platforms needed for rapid identification of biological threats, development of potential cures and global manufacturing of …
How biotech can revolutionize healthcare for the future | World ...
Nov 3, 2022 · For example, biotechnology in healthcare has maximized effectiveness by increasing medical personalization and individually designed treatments. In this direction, …
Biotechnology Innovation Organization | World Economic Forum
Biotechnology Innovation Organization (BIO) is among the world's largest trade associations representing biotechnology companies, academic institutions, state biotechnology centres and …
Technology convergence is leading us to the fifth industrial …
Jan 13, 2025 · Red biotech: Use of solutions, such as AI, for drug discovery, machine learning to identify plant-based natural compounds for new drug development, integration of microfluidic …
What is the bioeconomy and how can it drive sustainable …
Jul 12, 2024 · By integrating advances in biotechnology and digital tools with circular economy principles, the bioeconomy offers solutions that not only mitigate environmental impacts, but …
These are the Top 10 Emerging Technologies of 2024 - The World …
Jun 25, 2024 · The Forum’s pick of the Top 10 Emerging Technologies of 2024 range from microbial carbon capture to high altitude platform station systems.
Biotechnology: what it is and how it's about to change our lives
Dec 20, 2016 · Biotechnology is a broad range of technologies that employ living organisms or parts of them to make diverse products. For example, drugs and therapeutics, nutritional …
Biotechnology: From transforming healthcare to transforming our …
Sep 14, 2023 · Embracing biotechnology as the world’s go-to commercialization technology serves as a pro-environment alternative that permits industries to move beyond fossil inputs …
Four problems that biotechnology can help solve - The World …
Jun 27, 2016 · Biotechnology offers some of the most promising and targeted ways to find solutions to these threats. For example, the British company Oxitec, a subsidiary of Intrexon …
Explaining biotechnology, its achievements and potential
Jan 16, 2025 · When the biotechnology community tells stories in unique ways that provide a sense of optimism, we can win people over and encourage the adoption of new innovations …
How could biotechnology improve your life? - The World Economic …
Feb 25, 2013 · Biotechnology has the potential to provide the platforms needed for rapid identification of biological threats, development of potential cures and global manufacturing of …
How biotech can revolutionize healthcare for the future | World ...
Nov 3, 2022 · For example, biotechnology in healthcare has maximized effectiveness by increasing medical personalization and individually designed treatments. In this direction, …
Biotechnology Innovation Organization | World Economic Forum
Biotechnology Innovation Organization (BIO) is among the world's largest trade associations representing biotechnology companies, academic institutions, state biotechnology centres and …
Technology convergence is leading us to the fifth industrial …
Jan 13, 2025 · Red biotech: Use of solutions, such as AI, for drug discovery, machine learning to identify plant-based natural compounds for new drug development, integration of microfluidic …
What is the bioeconomy and how can it drive sustainable …
Jul 12, 2024 · By integrating advances in biotechnology and digital tools with circular economy principles, the bioeconomy offers solutions that not only mitigate environmental impacts, but …
These are the Top 10 Emerging Technologies of 2024 - The World …
Jun 25, 2024 · The Forum’s pick of the Top 10 Emerging Technologies of 2024 range from microbial carbon capture to high altitude platform station systems.
